You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Receptors, N-Methyl-D-Aspartate

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Therapy of Anti-NMDAR Encephalitis at Diagnosis

Active, not recruiting
  • Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Sep 4, 2023

    Developing Advanced Neuroimaging for Clinical Evaluation of

    Recruiting
    • Anti-N-Methyl-D-Aspartate Receptor Encephalitis
    • Autoimmune Encephalitis
    • Not applicable - non-interventional study
    • London, Greater London, United Kingdom
      Guy's and St Thomas' NHS Foundation Trust
    Jun 14, 2022

    Clinical-immunological Features of Anti-NMDAR Encephalitis

    Active, not recruiting
    • Anti NMDA Receptor Encephalitis
    • Description of clinical characteristic
    • Lyon, Bron, France
      Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
    Feb 12, 2023

    Psycho-social Impact of Anti-NMDAR Encephalitis

    Not yet recruiting
    • NMDAR Antibody-associated Auto-immune Encephalitis
    • standardized and validated surveys
    • Bron, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 13, 2023

    Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)

    Recruiting
    • Anti-NMDAR Encephalitis
    • Paris, France
      Hôpital Necker Enfants-Malades
    Oct 31, 2022

    Diagnostic Score for Encephalitis to Assess Risk of Autoimmune

    Recruiting
    • Autoimmune Encephalitis
    • Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
    • Clinical score of Granillo and al.
    • Lyon, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 12, 2023

    GWAS in NMDAR Encephalitis

    Recruiting
    • Autoimmune Encephalitis
    • GWAS
    • Lyon, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Feb 4, 2022

    NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)

    Not yet recruiting
    • NMDAR Autoimmune Encephalitis
    • LGI1 Autoimmune Encephalitis
    • Prague, Czechia
    • +1 more
    Aug 15, 2022

    Learning and Memory in Healthy Individuals and Those With Psychiatric Illness Trial in Chicago (GLYX-13, Placebo)

    Terminated
    • Learning and Memory in Healthy Individuals and Those With Psychiatric Illness
    • Chicago, Illinois
      Northwestern University
    Jan 14, 2022

    Breast Cancer Trial in Cairo (Bupivacaine Hydrochloride, Bupivacaine Hydrochloride and dexmedetomedine, Bupivacaine

    Recruiting
    • Breast Cancer
    • Bupivacaine Hydrochloride
    • +2 more
    • Cairo, Egypt
      Hanafy
    Feb 13, 2023

    Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)

    Recruiting
    • Rotator Cuff Tendinitis
    • Chronic Pain
    • Kristiansund, Norway
      Department of Orthopedic Surgery, Kristiansund Hospital
    Mar 15, 2022

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

    Not yet recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Jan 13, 2023

    Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

    Not yet recruiting
    • Depressive Disorder, Major
    • +2 more
    • New Haven, Connecticut
      Yale University
    Jun 26, 2023

    Refractory Epilepsy Trial in Birmingham (Traditional Treatment (Group T), Ketamine Infusion (Group K))

    Withdrawn
    • Refractory Epilepsy
    • Traditional Treatment (Group T)
    • Ketamine Infusion (Group K)
    • Birmingham, Alabama
      UAB Department of Anesthesiology and Perioperative Medicine
    May 18, 2021

    Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)

    Not yet recruiting
    • Depressive Disorder
    • +4 more
    • Perampanel 6 MG
    • +2 more
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Mar 14, 2023

    Paraneoplastic Neurologic Encephalitis and Mature Cystic

    Recruiting
    • Ovarian Dermoid Cyst
    • Blood sample
    • Rishon LeZion, Israel
      Shamir medical center
    Jan 23, 2022

    Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

    Not yet recruiting
    • Schizophrenia
    • Taichung, Taiwan
      Department of Psychiatry, China Medical University Hospital
    Sep 4, 2023

    Schizophrenia, Schizo Affective Disorder Trial in New York (D-serine, Placebo)

    Not yet recruiting
    • Schizophrenia
    • Schizo Affective Disorder
    • New York, New York
      New York State Psychiatric
    Jul 25, 2022

    S-ketamine, Postoperative Analgesia, Spine Fusion Trial in Beijing (S-ketamine, Placebo)

    Recruiting
    • S-ketamine
    • +2 more
    • Beijing, Beijing, China
      Beijing University First Hospital
    Apr 19, 2022

    Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • +2 more
    • New Haven, Connecticut
      Yale University
    Aug 8, 2022

    Episiotomy Wound, Pain, Procedural Trial (Magnesium sulfate)

    Not yet recruiting
    • Episiotomy Wound
    • Pain, Procedural
    • Magnesium sulfate
    • (no location specified)
    Jun 9, 2022

    Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,

    Recruiting
    • Oligometastatic Prostate Carcinoma
    • +2 more
    • Placebo Administration
    • +3 more
    • Decatur, Illinois
    • +2 more
    Aug 11, 2022

    Magnesium Sulfate Causing Adverse Effects in Therapeutic Use Trial in Mansoura (normal saline, MgSo4)

    Completed
    • Magnesium Sulfate Causing Adverse Effects in Therapeutic Use
    • Mansoura, Egypt
      Mahmoud S Elmansy
    Dec 14, 2021

    Treatment Resistant Schizophrenia Trial in Bhubaneswar (Dextromethorphan, Placebo)

    Not yet recruiting
    • Treatment Resistant Schizophrenia
    • Bhubaneswar, Odisha, India
      All India Institute of Medical Sciences (AIIMS)
    Jul 15, 2023

    Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine, Dexmedetomidine, Sufentanil)

    Active, not recruiting
    • Scoliosis Correction
    • +4 more
    • Beijing, Beijing, China
      Peking University First Hospital
    Feb 7, 2023